Axcella Health
decreases damage and immune cell recruitment and decreases | Axcella Health
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
28 of 62
Related slides by other companies
Matinas BioPharma
Investor Presentation
March 2024
are avidly taken up by innate immune cells multiple opportunities in inflammation tiple cog us | Matinas BioPharma
Genelux
Investor Presentation
December 2023
choice platform library vectors with | Genelux
Exscientia
Investor Presentation
June 2022
i sparing immune cells in comparison to i | Exscientia
Arbutus Biopharma
Investor Presentation
January 2024
specific cell responses and soluble immune increased after dosing | Arbutus Biopharma
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights